Septal Deviation Correction (Septoplasty) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Septoplasty is a surgical procedure to correct a deviated nasal septum — the thin partition of cartilage and bone that divides the nasal cavity into right and left passages. When the septum is displaced significantly to one side (deviated), it narrows the nasal airway, obstructing breathing, impairing sinus drainage, and disrupting sleep. Septoplasty repositions and reshapes the septal cartilage and bone so that both nasal passages are open and functional.

Nasal septal deviation affects an estimated 80% of the population to some degree, though only a minority experience symptoms severe enough to warrant surgery. The deviation may be congenital or acquired following nasal trauma (sports injuries, fractures). When combined with an external cosmetic reshaping of the nose, the combined procedure is called septorhinoplasty.

Anatomy of the Septum

The nasal septum is composed of three elements: the quadrangular cartilage anteriorly, the perpendicular plate of the ethmoid bone superiorly, and the vomer bone posteriorly and inferiorly. Deviation typically occurs at the junction of cartilage and bone (osseocartilaginous junction) or within the caudal septum near the columella. The precise anatomy of the deviation determines the surgical approach and technique.

Septoplasty is indicated when the following conditions are attributable to a structural nasal septum deviation and have not responded adequately to medical therapy:

• Chronic nasal obstruction: Persistent difficulty breathing through one or both nostrils. The most common indication for septoplasty; significantly impairs exercise tolerance and daytime energy levels.
• Chronic sinusitis: A deviated septum blocks the sinus ostia (drainage channels), predisposing to recurrent bacterial or fungal sinusitis. Septoplasty is often performed alongside functional endoscopic sinus surgery (FESS).
• Sleep-disordered breathing: Nasal obstruction increases upper airway resistance, contributing to snoring and obstructive sleep apnoea. Septoplasty may reduce snoring and improve CPAP tolerance, though it rarely cures obstructive sleep apnoea in isolation.
• Recurrent epistaxis (nosebleeds): Prominent septal spurs or deviated sections create turbulent airflow, drying and traumatising the nasal mucosa and precipitating bleeding.
• Headache and facial pressure: Septal deviation causing contact between the septum and the turbinate (contact headache) produces unilateral facial pain and pressure.
• Anosmia or reduced smell: When obstruction prevents odorant molecules from reaching the olfactory epithelium in the roof of the nasal cavity.

Candidates for septoplasty should satisfy the following criteria:

• Confirmed structural septal deviation on physical examination (anterior rhinoscopy, nasal endoscopy) or CT scan of the paranasal sinuses
• Symptoms attributable to the deviation (nasal obstruction, sinusitis, epistaxis, sleep disruption) that correlate with the side of deviation
• Failure or inadequate response to a 4–8 week trial of medical therapy, which typically includes intranasal corticosteroid spray (e.g., mometasone, fluticasone), saline irrigation, and antihistamines where allergic rhinitis coexists
• Age ≥16–18 years; the nasal skeleton should be fully developed before surgical correction. Exceptions exist for severe childhood nasal obstruction.
• Non-smoker or willingness to abstain for ≥4 weeks perioperatively to support mucosal healing
• No active nasal or sinus infection at the time of surgery (elective surgery should be delayed until infection resolves)

Patients with bleeding disorders require haematology review. Those taking aspirin, antiplatelet agents, or anticoagulants must stop these medications (under medical guidance) prior to surgery. Coexisting inferior turbinate hypertrophy, which often accompanies septal deviation, should be assessed and planned for concurrent treatment.

Standard Septoplasty (Endoscopic or Headlight-Assisted)

The procedure is performed entirely through the nostrils (endonasal approach) with no external incisions. Under general anaesthesia (or local anaesthesia with sedation in appropriate patients), the surgeon makes a hemitransfixion or Killian incision through the mucosal lining on one side of the septum. Mucoperichondrial flaps are elevated to expose the cartilage and bone. Deviated cartilage is straightened, scored, or partially excised, preserving the dorsal and caudal struts (minimum 1.5 cm L-strut) to maintain nasal support. Bony spurs are removed with a chisel or microdebrider. The flaps are repositioned and held with absorbable sutures or nasal splints.

Operative time: 45–90 minutes. Most patients are discharged the same day or after one overnight stay.

Septoplasty with Inferior Turbinate Reduction

Inferior turbinate hypertrophy frequently coexists with septal deviation (compensatory hypertrophy on the wider side). Concurrent turbinate reduction — by submucous resection, radiofrequency ablation, or microdebrider-assisted turbinoplasty — improves airflow outcomes beyond septoplasty alone and is performed in the same session.

Septorhinoplasty

When the patient also desires correction of the external nasal shape (crooked nose, dorsal hump, nasal tip refinement), septoplasty is combined with rhinoplasty. The combined approach uses the septal cartilage removed during septoplasty as graft material to reconstruct the nasal framework. More complex and carries a longer recovery than septoplasty alone.

Functional Endoscopic Sinus Surgery (FESS) + Septoplasty

When chronic sinusitis accompanies the deviation, FESS is performed simultaneously to open the sinus ostia, allowing ventilation and drainage. Reduces the need for two separate procedures under anaesthesia.

Evidence from systematic reviews and large case series supports the following outcomes for septoplasty:

• Nasal airway improvement: Objective rhinomanometry and acoustic rhinometry demonstrate significant increase in nasal airflow cross-sectional area in over 85% of patients. Patient-reported nasal obstruction scores (NOSE scale, SNOT-22) improve substantially in most series.
• Sleep quality: Apnoea-hypopnoea index (AHI) modestly improves, and patients report better sleep quality and reduced snoring frequency. Concurrent turbinate reduction enhances this benefit.
• Sinus disease control: When performed alongside FESS, sinusitis recurrence rates and antibiotic prescription frequency decline significantly.
• Nosebleed resolution: Removal of septal spurs and smoothing of the mucosa reduces contact bleeding in the majority of patients.
• Durability: Improvements are sustained at 5–10 year follow-up in the large majority of patients. Re-deviation is uncommon when adequate cartilage struts are preserved.

Septoplasty is considered a low-risk procedure, but as with all surgery, complications may occur:

Common (5–10%)

• Temporary nasal congestion, crusting, and discharge for 2–4 weeks during mucosal healing
• Mild epistaxis in the first 48–72 hours, usually self-limiting
• Temporary altered sense of smell (hyposmia); resolves as swelling subsides

Uncommon (1–5%)

• Septal haematoma — blood collecting between the cartilage and mucosa; requires urgent surgical drainage to prevent cartilage necrosis
• Infection (perichondritis, sinusitis) — treated with antibiotics; rare with appropriate perioperative prophylaxis
• Septal perforation — a hole through the septum; most small perforations are asymptomatic, though larger ones may whistle or bleed and require repair
• Nasal tip or dorsal collapse due to over-resection of cartilage (saddle nose deformity)

Rare (<1%)

• Cerebrospinal fluid (CSF) leak from disruption of the cribriform plate (more likely with extensive posterior dissection)
• Anosmia — permanent loss of smell (extremely rare)
• Synechia (adhesion) formation between the septum and turbinate, causing nasal obstruction; prevented by splints

Post-operative fever, worsening pain, or clear fluid dripping from the nose should prompt immediate medical review.

Immediate Post-Operative Period (Days 1–7)

Nasal packs (if placed) are removed at 24–48 hours. Internal silicone splints, when used, remain for 5–7 days. The nose should not be blown forcefully for 2 weeks. Saline nasal irrigations (twice daily) commence on day 2 to prevent crusting and support mucosal healing. Patients should sleep with the head elevated to reduce swelling and bleeding risk.

Short-Term Recovery (Weeks 1–4)

Most patients return to desk work and light activity within 7–10 days. Strenuous exercise, heavy lifting, and contact sports are avoided for 3–4 weeks. Nasal congestion remains a prominent symptom for 2–6 weeks as the mucosa heals and swelling resolves — many patients underestimate the duration before perceiving airway improvement.

Long-Term Follow-Up

Formal endoscopic review at 4–6 weeks assesses septal position, turbinate status, and sinus drainage. Any residual synechia is divided under local anaesthesia at this visit. Intranasal corticosteroid spray may be continued for 3–6 months post-operatively to reduce mucosal swelling and optimise airway patency. Patients who do not achieve expected improvement by 3 months should be reassessed with repeat CT sinus imaging to identify residual anatomical obstruction.

The cost of septoplasty varies widely depending on the following factors:

• Procedure scope: Simple septoplasty alone is less expensive than septoplasty combined with turbinate reduction, FESS, or rhinoplasty. Each added component increases operative time and anaesthesia costs.
• Setting: Day-case procedures in ambulatory surgery centres are less expensive than inpatient hospital procedures.
• Country: Septoplasty in India, Thailand, or Turkey is typically 60–75% less expensive than in the United States or United Kingdom. India in particular has a large pool of experienced ENT-head and neck surgeons with competitive pricing at accredited hospitals.
• Insurance coverage: Septoplasty performed for functional indications (nasal obstruction, chronic sinusitis, sleep apnoea) is typically covered by health insurance when medical management has been documented to have failed. The cosmetic component of a septorhinoplasty is excluded from coverage.
• Surgeon experience and technology: Endoscopic or image-guided approaches involve equipment costs reflected in the fee. High-volume centres with advanced imaging may offer better outcomes for complex cases.

Before surgery, the following medical and non-surgical options should be trialled:

• Intranasal corticosteroid sprays (INCS): First-line pharmacotherapy for nasal obstruction with allergic or inflammatory components (mometasone, fluticasone, budesonide). Reduces turbinate swelling and inflammation but does not correct structural deviation.
• Nasal decongestants (oxymetazoline, xylometazoline): Short-term relief of nasal obstruction; not suitable for prolonged use due to rhinitis medicamentosa risk (rebound congestion with use beyond 5–7 days).
• Saline nasal irrigation: High-volume hypertonic or isotonic nasal rinse (Neti pot, SinuRinse) supports mucosal clearance and reduces crusting. An adjunct, not a treatment for structural deviation.
• Nasal dilator strips (Breathe Right): External nasal strips provide temporary improvement in nasal valve function and may help with sleep-related breathing without surgery.
• CPAP therapy: For patients with obstructive sleep apnoea, CPAP remains the most effective therapy. Septoplasty may improve CPAP tolerance by reducing the pressure required, but does not replace CPAP in moderate-to-severe OSA.
• Radiofrequency turbinate reduction: An in-office procedure under local anaesthesia that reduces inferior turbinate size using radiofrequency energy. Less invasive than formal turbinoplasty; suitable when turbinate hypertrophy is the predominant cause and the septum is only mildly deviated.